Mesoblast Limited (LWB) - Total Liabilities

Latest as of December 2025: €207.62 Million EUR ≈ $242.73 Million USD

Based on the latest financial reports, Mesoblast Limited (LWB) has total liabilities worth €207.62 Million EUR (≈ $242.73 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Mesoblast Limited (LWB) equity growth momentum to track the company's year-over-year net asset growth rate.

Mesoblast Limited - Total Liabilities Trend (2014–2025)

This chart illustrates how Mesoblast Limited's total liabilities have evolved over time, based on quarterly financial data. See LWB free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Mesoblast Limited Competitors by Total Liabilities

The table below lists competitors of Mesoblast Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Bukit Asam Tbk PT JK:PTBA	Indonesia	Rp19.56 Trillion
Odontoprev S.A SA:ODPV3	Brazil	R$958.26 Million
Dalian Huarui Heavy Industry Group Co Ltd SHE:002204	China	CN¥19.40 Billion
Yantai Dongcheng Pharmaceutical Co Ltd SHE:002675	China	CN¥3.77 Billion
Zhejiang Expressway Co. Ltd F:ZHJ	Germany	€200.36 Billion
Maxvision Technology Corp SHE:002990	China	CN¥1.10 Billion
Solvac S.A. BR:SOLV	Belgium	€215.41 Million
CITIC Guoan Information Industry Co Ltd SHE:000839	China	CN¥4.90 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down Mesoblast Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see LWB market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.58	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.36	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.27	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Mesoblast Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Mesoblast Limited (2014–2025)

The table below shows the annual total liabilities of Mesoblast Limited from 2014 to 2025.

Year	Total Liabilities	Change
2025-06-30	€187.24 Million ≈ $218.90 Million	-0.82%
2024-06-30	€188.80 Million ≈ $220.72 Million	+12.66%
2023-06-30	€167.58 Million ≈ $195.92 Million	+1.50%
2022-06-30	€165.10 Million ≈ $193.02 Million	+1.09%
2021-06-30	€163.32 Million ≈ $190.94 Million	-11.37%
2020-06-30	€184.28 Million ≈ $215.44 Million	+7.72%
2019-06-30	€171.06 Million ≈ $199.99 Million	+16.82%
2018-06-30	€146.44 Million ≈ $171.20 Million	+5.41%
2017-06-30	€138.92 Million ≈ $162.41 Million	-10.87%
2016-06-30	€155.86 Million ≈ $182.21 Million	-50.33%
2015-06-30	€313.78 Million ≈ $366.84 Million	+1.56%
2014-06-30	€308.95 Million ≈ $361.20 Million	--

About Mesoblast Limited

F:LWB Germany Biotechnology

Market Cap

$1.79 Billion

€1.53 Billion EUR

Market Cap Rank

#6964 Global

#1002 in Germany

Share Price

€1.18

Change (1 day)

-2.03%

52-Week Range

€1.06 - €1.71

All Time High

€3.48